References in periodicals archive ?
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
iii) Test was considered to be mixed infection if one line appear in the control region, one in the plasmodium falciparum region and one in the pan malarial region.
The heterozygous genotype showed no significant effect in modulating the probability of acquisition of malaria caused by Plasmodium falciparum (OR: 1.
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
The Plasmodium Falciparum infection was more predominant (n=48) as the area is more endemic.
Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-py rimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Longitudinal surveillance of in vitro pyrimethamine resistance in Plasmodium falciparum.
Plasmodium vivax is more frequent than Plasmodium falciparum.
Amongst the four species of Plasmodium that transmit human malaria, Plasmodium falciparum is responsible forthe most severe clinical manifestations of disease and causes most malaria morbidity and almost all malaria mortality [3].
This new target comes in addition to the original 2006 Roadmap's goal of having a licensed vaccine against Plasmodium falciparum malaria, the most deadly form of the disease, for children under 5 years of age in sub-Saharan Africa by 2015.

Full browser ?